Picture of Inspecs logo

SPEC Inspecs News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - Inspecs Group PLC - Director/PDMR Share Dealing

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220302:nRSB2877Da&default-theme=true

RNS Number : 2877D  Inspecs Group PLC  02 March 2022

2 March 2022

Inspecs Group Plc

("Inspecs" the "Company" or "Group")

 

Director/PDMR Share Dealing

 

On 28 February 2022, the following options to acquire Ordinary Shares of 1
pence each in the capital of the Company ("Ordinary Shares") were granted
under the Inspecs Long Term Incentive Plan 2020 ("LTIP") to Chris Kay, the
Chief Financial Officer of the Group. The option entitles the optionholder to
acquire 183,153 Ordinary Shares at an exercise price of 375 pence per Ordinary
Share. The option vests on the 28 February 2025, being the third anniversary
of grant, subject to the optionholder's continued employment with the Group.

 

 1.   Details of the person discharging managerial responsibilities/person
 closely associated

 a)   Name                                                           Christopher Kay
 2.   Reason for the notification
 a)   Position/status                                                Chief Financial Officer
 b)   Initial notification / Amendment                               Initial notification
 3.   Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 a)   Name                                                           Inspecs Group plc
 b)   LEI                                                            2138008Z4S4DHR6NE933
 4.   Details of the transaction(s): section to be repeated for (i) each type
 of instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 a)   Description of the financial instrument, type of instrument    Ordinary Shares of 1 pence
 b)   Identification code                                            GB00BK6JPP03
 c)   Nature of the transaction                                      Grant of options over 183,153 ordinary shares with an exercise price of £3.75
                                                                     per share under the Inspecs Long Term Incentive Plan
 d)   Price(s) and volume(s)                                             Price(s)  Volume(s)
                                                                         £3.75     183,153
 e)   Aggregated information:                                        N/A

 i. Aggregated volume

 ii. price
 f)    Date of the transaction                                       28 February 2022
 g)   Place of the transaction                                       Outside a trading venue

2.   Reason for the notification

 

a)   Position/status

 Chief Financial Officer

b)   Initial notification / Amendment

Initial notification

3.   Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)   Name

Inspecs Group plc

b)   LEI

2138008Z4S4DHR6NE933

4.   Details of the transaction(s): section to be repeated for (i) each type
of instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)   Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b)   Identification code

GB00BK6JPP03

c)   Nature of the transaction

Grant of options over 183,153 ordinary shares with an exercise price of £3.75
per share under the Inspecs Long Term Incentive Plan

d)   Price(s) and volume(s)

     Price(s)  Volume(s)
     £3.75     183,153

e)   Aggregated information:

i. Aggregated volume

ii. price

N/A

f)    Date of the transaction

28 February 2022

g)   Place of the transaction

Outside a trading venue

 

For further information please contact:

 

 Inspecs Group plc                         via FTI Consulting

 Robin Totterman (CEO)                     Tel: +44 (0) 20 3727 1000

 Chris Kay (CFO)

 Peel Hunt (Nominated Adviser and Broker)  Tel: +44 (0) 20 7418 8900

 Adrian Trimmings

 Andrew Clark

 FTI Consulting (Financial PR)             Tel: +44 (0) 20 3727 1000

 Alex Beagley

 Alice Newlyn

 Harriet Jackson

 

About Inspecs Group plc

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear
frames and optically advanced spectacle lenses. The Group produces a broad
range of frames and lenses, covering optical, sunglasses and safety, which are
either "Branded" (either under licence or under the Group's own proprietary
brands), or "OEM" (including private label on behalf of retail customers and
un-branded).

INSPECS aims to be the leader in eyewear solutions through its
vertically-integrated business model and has adopted a three pillar growth
strategy to achieve this: (i) continue to grow organically; (ii) undertake
further acquisitions (and drive value through leveraging the Group's internal
capabilities); and (iii) extend the Group's manufacturing capacity.

 

The Group has completed a number of significant acquisitions since its IPO in
February 2020. In December 2020, INSPECS acquired Eschenbach, a leading,
global, eyewear supplier headquartered in Nuremberg, Germany, which includes
the American company Tura. This followed the acquisition of lens maker
Norville in July 2020, whereby INSPECS combined two heritage brands in British
optical, Savile Row frame maker, and Norville lens maker, further enhancing
its vertically integrated business model. In December 2021 the Group acquired
Ego Eyewear, a design and licensing company which uses third party eyewear
manufacturers to produce premium fashion brands, and BoDe, a distributor of
optical and sunglasses frames principally to the German market.

 

INSPECS customers include global optical and non-optical retailers, global
distributors and independent opticians, with its distribution network covering
over 80 countries and reaching approximately 70,000 points of sale.

 

INSPECS has operations across the globe: with offices in the UK, Portugal,
Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and
manufacturing facilities in Vietnam, China, the UK and Italy. With the
acquisition of Eschenbach, the Group's international reach further extends
across Europe and the American markets.

 

More information is available at: https://inspecs.com (https://inspecs.com)
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHVFLFBLXLZBBF

Recent news on Inspecs

See all news